Evaluation of a novel collagen-gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse model

Journal of Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 1, 2014, Pages 29-40

  Kanda, Norikazu ^a   Morimoto, Naoki ^a   Ayvazyan, Artem A ^a   Takemoto, Satoru ^b   Kawai, Katsuya ^a   Nakamura, Yoko ^a   Sakamoto, Yuki ^c   Taira, Tsuguyoshi ^c   Suzuki, Shigehiko ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Matsue City Hospital   (Japan)

^c Gunze Research and Development Center   (Japan)

Author keywords

Artificial skin; BFGF; Collagen gelatin sponge; Diabetic mice; Scaffold; Sustained release; Wound healing

Indexed keywords

ARTIFICIAL ORGANS; BIODEGRADATION; CAPILLARITY; CELL CULTURE; DISEASES; FIBROBLASTS; MAMMALS; MICROCIRCULATION; SCAFFOLDS (BIOLOGY); TISSUE;

ARTIFICIAL SKIN; BASIC FIBROBLAST GROWTH FACTOR; BFGF; COLLAGEN-GELATIN SPONGE; DECUBITUS; DIABETIC MICE; GELATIN SPONGE; SALINE SOLUTIONS; SUSTAINED RELEASE; WOUND HEALING;

COLLAGEN;

ATELOCOLLAGEN; COLLAGEN GELATIN SPONGE; COLLAGEN SPONGE; GELATIN SPONGE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CAPILLARY; CELL COUNT; CONTROLLED STUDY; DEBRIDEMENT; DECUBITUS; DERMIS; DIABETES MELLITUS; DRUG EFFICACY; HUMAN; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TISSUE REGENERATION; TISSUE REPAIR; WOUND; WOUND HEALING;

ARTIFICIAL SKIN; BFGF; COLLAGEN-GELATIN SPONGE; DIABETIC MICE; SCAFFOLD; SUSTAINED RELEASE; WOUND HEALING;

ANIMALS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLAST GROWTH FACTOR 2; GELATIN; MICE; TISSUE SCAFFOLDS;

EID: 84891625645     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1492     Document Type: Article

References (52)

1. Artem A, Naoki M, Norikazu K et al. 2011; Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs. J Surg Res 171: e247-e257.
2. Akita S, Akino K, Tanaka K et al. 2008; A basic fibroblast growth factor improves lower extremity wound healing with a porcine-derived skin substitute. J Trauma 64(3): 809-815.
3. Bhansali A, Venkatesh S, Dutta P et al. 2009; Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast? Diabetes Res Clin Pract 83(1): e13-e16.
4. Baroni G, Porro T, Faglia E et al. 1987; Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 10(1): 81-86.
5. Cervelli V, Gentile P, Scioli MG et al. 2009; Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods 15(4): 625-634.
6. Cervelli V, Lucarini L, Cerretani C et al. 2010; The use of Matriderm and autologous skin grafting in the treatment of diabetic ulcers: a case report. Int Wound J 7(4): 291-296.
7. Collier M. 2009; Silver dressings: more evidence is needed to support their widespread clinical use. J Wound Care 18(2): 77-78.
8. Dunn R, Dolianitis C. 2008; Prolidase deficiency: the use of topical proline for treatment of leg ulcers. Australas J Dermatol 49(4): 237-238.
9. Eran B, David M, Eyal W. 2006; Skin substitutes. The Israel Medical Association Journal 8: 188-191.
10. Fu X, Shen Z, Guo Z et al. 2002; Healing of chronic cutaneous wounds by topical treatment with basic fibroblast growth factor. Chin Med J [Engl] 115(3): 331-335.
11. Gospodarowicz D. 1974; Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249(453): 123-127.
12. Heyneman A, Beele H, Vanderwee K et al. 2008; A systematic review of the use of hydrocolloids in the treatment of pressure ulcers. J Clin Nurs 17(9): 1164-1173.
13. Ho C, Tran K, Hux M et al. 2005; Artificial skin grafts in chronic wound care: a meta-analysis of clinical efficacy and a review of cost-effectiveness. Technol Rep 52: 1-63.
14. Hong L, Tabata Y, Miyamoto S et al. 2000; Bone regeneration at rabbit skull defects treated with transforming growth factor-β1 incorporated into hydrogels with different levels of biodegradability. J Neurosurg 92(2): 315-325.
15. Ito K, Ito S, Sekine M et al. 2005; Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor. Plast Reconstr Surg 115(2): 567-572.
16. Kanda N, Morimoto N, Takemoto S et al. 2011; Efficacy of novel collagen-gelatin scaffold with sustained release of basic fibroblast growth factor for dermis-like tissue regeneration. Ann Plast Surg. [Epub ahead of print].
17. Kanematsu A, Yamamoto S, Ozeki M et al. 2004; Collagenous matrices as release carriers of exogenous growth factors. Biomaterials 25(18): 4513-4520.
18. Karr J. 2008; Utilization of living bilayered cell therapy (Apligraf) for heel ulcers. Adv Skin Wound Care 21(6): 270-274.
19. Kathleen M, Lacci, M, PA-C et al. 2010; Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med 83(1): 1-9.
20. Kawai K, Suzuki S, Tabata Y et al. 2000; Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial skin. Biomaterials 21(5); 489-499.
21. Kawai K, Suzuki S, Tabata Y et al. 2001; Development of an artificial dermis preparation capable of silver sulfadiazine release. J Biomed Mater Res 57(3): 346-356.
22. Kawai K, Suzuki S, Tabata Y et al. 2005; Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. Br J Plast Surg 58(8): 1115-1123.
23. Kessler L, Bilbault P, Ortéga F et al. 2003; Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care 26(8): 2378-2382.
24. Kim YS, Lew DH, Tark KC et al. 2010; Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing. J Korean Med Sci 25(4): 589-596.
25. Kimura Y, Tsuji W, Yamashiro H et al. 2010; In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor. J Tissue Eng Regen Med 4(1): 55-61.
26. Kurokawa I, Hayami J, Kita Y. 2003; A therapy-resistant chronic leg ulcer treated successfully with topical basic fibroblast growth factor. J Int Med Res 31(2): 149-151.
27. Kuroyanagi Y, Yamada N, Yamashita R et al. 2001; Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 25(3): 180-186.
28. Labanaris AP, Polykandriotis E, Horch RE. 2009; The effect of vacuum-assisted closure on lymph vessels in chronic wounds. J Plast Reconstr Aesthet Surg 62(8): 1068-1075.
29. Langer R. 2007; Tissue engineering: perspectives, challenges, and future directions. Tissue Eng 13(1): 1-2.
30. Matsuda K, Suzuki S, Isshiki N. 1992; Evaluation of a bilayer artificial skin capable of sustained release of an antibiotic. Biomaterials 13(2): 119-122.
31. Matsuda K, Suzuki S, Isshiki N et al. 1991; A bilayer 'artificial skin' capable of sustained release of an antibiotic. Br J Plast Surg 44(2): 142-146.
32. Matsuda K, Suzuki S, Ihiki N. 1988; Experiments on sustained release of an antibiotic from bilayer artificial skin. Japan J Burn Inj 14: 202.
33. McCallon SK, Hurlow J. 2009; Clinical applications for the use of enzymatic debriding ointment and broad-spectrum bacteriostatic foam dressing. J Wound Ostomy Continence Nurs 36(6, suppl): 17-24.
34. Mirabet V, Solves P, Miñana MD et al. 2008; Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Bank 9(1): 1-10.
35. Molnar JA, DeFranzo AJ, Hadaegh A et al. 2004; Acceleration of Integra incorporation in complex tissue defects with subatmospheric pressure. Plast Reconstr Surg 113(5): 1339-1346.
36. Motomura K, Hagiwara A, Komi-Kuramochi A et al. 2008; An FGF1:FGF2 chimeric growth factor exhibits universal FGF receptor specificity, enhanced stability and augmented activity useful for epithelial proliferation and radioprotection. Biochim Biophys Acta 1780(12): 1432-1440.
37. Muneuchi G, Suzuki S, Moriue T et al. 2005; Combined treatment using artificial dermis and basic fibroblast growth factor (bFGF) for intractable fingertip ulcers caused by atypical burn injuries. Burns 31(4): 514-517.
38. Muniruzzaman, Tabata Y, Ikada Y. 1998; Complexation of basic fibroblast growth factor with gelatin. J Biomater Sci Polym Ed 9(5): 459-473.
39. Nather A, Chionh SB, Han AY et al. 2010; Effectiveness of vacuum-assisted closure (VAC) therapy in the healing of chronic diabetic foot ulcers. Ann Acad Med Singapore 39(5): 353-358.
40. Nishizawa K, Imai S, Mimura T et al. 2010; In-advance trans-medullary stimulation of bone marrow enhances spontaneous repair of full-thickness articular cartilage defects in rabbits. Cell Tissue Res 341(3): 371-379.
41. Ohara N, Mihara S, Nihara H et al. 2010; A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute. J Artif Organs 13(2): 101-105.
42. Okumura M, Okuda T, Nakamura T et al. 1996; Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 19(4): 530-535.
43. Ong M. 2008; Hyperbaric oxygen therapy in the management of diabetic lower limb wounds. Singapore Med J 49(2): 105-109.
44. Oriani G, Meazza D, Favales F et al. 1990; Hyperbaric oxygen therapy in diabetic gangrene. J Hyperb Med 5(3): 171-175.
45. Pollard RL, Kennedy PJ, Maitz PK. 2008; The use of artificial dermis (Integra) and topical negative pressure to achieve limb salvage following soft-tissue loss caused by meningococcal septicaemia. J Plast Reconstr Aesthet Surg 61(3): 319-322.
46. Suzuki S, Matsuda K, Isshiki N et al. 1990a; Clinical evaluation of a new bilayer 'artificial skin' composed of collagen sponge and silicone layer. Br J Plast Surg 43(1): 47-54.
47. Suzuki S, Matsuda K, Isshiki N et al. 1990b; Experimental study of a newly developed bilayer artificial skin. Biomaterials 11(5): 356-360.
48. Tabata Y, Nagano A, Ikada Y. 1999; Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5(2): 127-138.
49. Takemoto S, Morimoto N, Kimura Y et al. 2008; Preparation of collagen-gelatin sponge scaffold for sustained release of bFGF. Tissue Eng 14(10): 1629-1638.
50. Tsuji-Saso Y, Kawazoe T, Morimoto N et al. 2007; Incorporation of basic fibroblast growth factor into preconfluent cultured skin substitute to accelerate neovascularisation and skin reconstruction after transplantation. Scand J Plast Reconstr Surg Hand Surg 41(5): 228-235.
51. Uchi H, Igarashi A, Urabe K et al. 2009; Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 19(5): 461-468.
52. Yannas IV, Burke JF, Gordon PL et al. 1980; Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 14(2): 107-132.